Neurotech Devices Market Players:
- EndoStim Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Natus Medical
- Allengers Medical Systems Ltd.
- Canon Medical Systems Corporation
- Elekta Solutions AB
- GE HealthCare Technologies Inc.
- Siemens Healthcare GmbH
- The Magstim Company Limited
- Tristan Technologies Inc.
- Abbott Laboratories Inc.
The primary participants in the neurotech devices market have consolidated, as seen by the rise in patent transfers, mergers and acquisitions, product launches, joint ventures, higher R&D expenditures, and product consolidation among domestic and international companies. Some of the prominent participants working in the neurotech devices industry are:
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of neurotech devices is evaluated at USD 18.24 billion.
The global neurotech devices market size exceeded USD 16.16 billion in 2025 and is set to expand at a CAGR of over 14.3%, surpassing USD 61.5 billion revenue by 2035.
North America neurotech devices market will dominate around 41% share by 2035, fueled by high prevalence of neurological disorders and rising patient numbers.
Key players in the market include EndoStim Inc., Natus Medical, Allengers Medical Systems Ltd., Canon Medical Systems Corporation, Elekta Solutions AB, GE HealthCare Technologies Inc., Siemens Healthcare GmbH, The Magstim Company Limited, Tristan Technologies Inc., Abbott Laboratories Inc.
